<?xml version="1.0" encoding="UTF-8"?>
<ref id="CR12">
 <label>12.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Zhao</surname>
    <given-names>X</given-names>
   </name>
   <name>
    <surname>Lapalombella</surname>
    <given-names>R</given-names>
   </name>
   <name>
    <surname>Joshi</surname>
    <given-names>T</given-names>
   </name>
   <name>
    <surname>Cheney</surname>
    <given-names>C</given-names>
   </name>
   <name>
    <surname>Gowda</surname>
    <given-names>A</given-names>
   </name>
   <name>
    <surname>Hayden-Ledbetter</surname>
    <given-names>MS</given-names>
   </name>
   <etal/>
  </person-group>
  <article-title>Targeting CD37-positive lymphoid malignancies with a novel engineered small modular immunopharmaceutical</article-title>
  <source>Blood</source>
  <year>2007</year>
  <volume>110</volume>
  <fpage>2569</fpage>
  <lpage>2577</lpage>
  <pub-id pub-id-type="doi">10.1182/blood-2006-12-062927</pub-id>
  <?supplied-pmid 17440052?>
  <pub-id pub-id-type="pmid">17440052</pub-id>
 </element-citation>
</ref>
